Versant Capital Management
CDNA icon

Versant Capital Management’s CareDx CDNA Stock Holding History

Versant Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$44.8K Sell
689
-269
-28% -$12.2K ﹤0.01% 1474
2026
Q2 		$27.3K Hold
958
– – ﹤0.01% 1764
2026
Q1 		$16.6K Buy
958
+87
+10% +$1.65K ﹤0.01% 1902
2025
Q4 		$16.4K Hold
871
– – ﹤0.01% 1754
2025
Q3 		$12.7K Buy
871
+776
+817% +$11.1K ﹤0.01% 1830
2025
Q2 		$1.86K Buy
+95
New +$1.69K ﹤0.01% 2397

Other funds holding CDNA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Zweig-DiMenna Associates
Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Versant Capital Management's CDNA Position: Q3 2026 in Review

Versant Capital Management reduced its CareDx (CDNA) stake by 28% in Q3 2026, selling an estimated $12.2K and leaving 689 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Versant Capital Management first reported a position in CDNA in Q2 2025 and has held it in 6 quarters since. 140 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Versant Capital Management held 689 shares of CareDx worth $44.8K as of Q3 2026.
  • Versant Capital Management sold 269 CareDx shares in Q3 2026, an estimated $12.2K.
  • CareDx made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1474 holding.
  • Versant Capital Management first reported a position in CareDx in Q2 2025 and has held it in 6 quarters since.
  • 140 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.